In a previous retrospective study, a persistent hyperactivation of the cAP—identified in patients with persistently low serum C3 levels six months after initiating immunosuppressive therapy for a first episode of proliferative LN—was associated with the progression of renal damage and the development of ESKD over the long term (18). Here, C3 is linked to lobular neoplasia.